# A Blinded Study to Evaluate Effect on Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation

Study · id `cardio:ct-nct02156076` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02156076](<https://clinicaltrials.gov/study/NCT02156076>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02156076

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 158 participants.

## Technical summary

Registry record NCT02156076. Randomized; quadruple masking; primary purpose other. Start 2014-07-25 (actual); primary completion 2016-06-01 (actual). Results posted on 2019-05-22.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose other
- Phase: Phase 2
- Enrolled: 158 participants (enrolled count; ClinicalTrials.gov record NCT02156076, source copy `cardio:ctgov-nct02156076-2019-07-31`, retrieved 2026-10-26)
- Started: 2014-07-25 (actual) (ClinicalTrials.gov record NCT02156076, source copy `cardio:ctgov-nct02156076-2019-07-31`, retrieved 2026-10-26)
- Primary completion: 2016-06-01 (actual) (ClinicalTrials.gov record NCT02156076, source copy `cardio:ctgov-nct02156076-2019-07-31`, retrieved 2026-10-26)
- Completion: 2016-06-01 (actual) (ClinicalTrials.gov record NCT02156076, source copy `cardio:ctgov-nct02156076-2019-07-31`, retrieved 2026-10-26)
- Results first posted: 2019-05-22 (ClinicalTrials.gov record NCT02156076, source copy `cardio:ctgov-nct02156076-2019-07-31`, retrieved 2026-10-26)
- Countries: United States; Canada (ClinicalTrials.gov record NCT02156076, source copy `cardio:ctgov-nct02156076-2019-07-31`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02156076-2019-07-31`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Blinded Study to Evaluate Effect on Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation
- Condition: Paroxysmal Atrial Fibrillation
- Intervention (Drug): BMS-919373
- Intervention (Drug): Placebo (Matching with BMS-919373)
- Lead sponsor: Bristol-Myers Squibb
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Bristol-Myers Squibb (`cardio:org-bristol-myers-squibb`)

## Provenance

Content hash: 2e51c267d7ea8c2b34b93293bf2b91cca06ea72726026d6cd518b7d25d1d04fb
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
